Real-world febrile neutropenia rates with same-day versus next-day pegfilgrastim after myelosuppressive chemotherapy

聚乙二醇非格司亭 医学 发热性中性粒细胞减少症 菲格拉斯汀 化疗 中性粒细胞减少症 内科学 肿瘤科 外科
作者
Kyle Kitchen,Michael Mosier
出处
期刊:Future Oncology [Future Medicine]
卷期号:18 (23): 2551-2560 被引量:1
标识
DOI:10.2217/fon-2022-0365
摘要

Aim: To compare the incidence of febrile neutropenia (FN) after same-day versus next-day pegfilgrastim. Materials & methods: This single-institution, real-world, retrospective electronic health record-based study included patients who received chemotherapy and prophylactic same-day or next-day pegfilgrastim/pegfilgrastim-cbqv. Results: In cycle 1, 117 patients received same-day pegfilgrastim and 180 patients received next-day pegfilgrastim. FN episodes in cycle 1 occurred in 6.0 versus 6.7% of patients with same-day versus next-day pegfilgrastim, respectively (p = 0.814). Across all cycles, 8.5 and 9.4% of patients experienced ≥1 FN episode after same-day versus next-day pegfilgrastim, respectively (p = 0.793). In the breast cancer patient subgroup, FN occurred 3.2% of same-day pegfilgrastim cycles versus 1.8% of next-day pegfilgrastim cycles (p = 0.938). Conclusion: No significant differences were detected between same-day and next-day pegfilgrastim administration.A common side effect of chemotherapy is the unintended killing of important immune cells that can fight infections. Because of this effect, patients with cancer who are treated with chemotherapy can experience a serious, sometimes deadly condition called febrile neutropenia (FN). Pegfilgrastim is a medication that is usually given on the day after chemotherapy to help immune cells grow and prevent FN. Many patients prefer to have pegfilgrastim administered on the same day as chemotherapy to avoid a second clinic visit, but it has not been proven whether this approach is as effective and safe as giving pegfilgrastim a day later. This study from the Utah Cancer Specialists in patients with various tumor types (e.g., breast cancer, lung cancer) showed that similar, low proportions of patients had FN when they were given pegfilgrastim on the same day as or the day after chemotherapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
斯文败类的应助被家里两只猫采纳,获得10
刚刚
情怀的应助被123采纳,获得10
1秒前
lvy完成签到,获得积分10
1秒前
Ivy发布了新的文献求助10
1秒前
李健的应助被camile采纳,获得10
1秒前
Lucas的应助被张zh采纳,获得10
2秒前
哇咔咔完成签到,获得积分10
2秒前
王ym发布了新的文献求助10
2秒前
科研通AI2S的应助被xiaoxin采纳,获得10
2秒前
夜九发布了新的文献求助10
3秒前
壳壳完成签到,获得积分10
3秒前
合适幼荷发布了新的文献求助10
4秒前
丘比特的应助被小西采纳,获得10
5秒前
5秒前
WANGL发布了新的文献求助10
6秒前
打打的应助被让地球种满香菜采纳,获得10
6秒前
6秒前
7秒前
小鱼爱吃肉的应助被上官小怡采纳,获得10
7秒前
8秒前
汉堡包的应助被梁透了采纳,获得10
8秒前
9秒前
传奇3的应助被Tiam采纳,获得10
9秒前
9秒前
9秒前
CipherSage的应助被YYZLHMHM采纳,获得10
9秒前
9秒前
10秒前
orixero的应助被Yahooo采纳,获得10
10秒前
Charles完成签到,获得积分10
10秒前
10秒前
CC小鱼发布了新的文献求助10
10秒前
Ava的应助被小黑球采纳,获得10
11秒前
欧尼酱完成签到 ,获得积分10
11秒前
xyz发布了新的文献求助10
11秒前
11秒前
11秒前
12秒前
英俊的铭的应助被yck采纳,获得10
12秒前
1111完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8154737
求助须知:如何正确求助?哪些是违规求助? 9551274
关于积分的说明 21703821
捐赠科研通 7744087
什么是DOI,文献DOI怎么找? 3425933
关于科研通互助平台的介绍 2551048
邀请新用户注册赠送积分活动 2469643